| Market Cap | — | |
| Enterprise Value | — | |
| Revenue | — | — |
| Gross Profit | — | — |
| EBITDA | €90.5M | +4.5% |
| Net Income | €55.5M | +4.9% |
| Diluted EPS | — | — |
| Free Cash Flow | €54.1M | −6.6% |
| DPS (FY2024) | — |
| Trailing yield | — |
| Payout ratio | 47.1% |
| Growth streak | — |
| 5y DPS growth | — |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20242024-12-31 | — | — | reported |
| FY20232023-12-31 | — | — | reported |
| Ratio | 2023 | 2024 | Trend · 2y | vs own |
|---|---|---|---|---|
| ▾Returns on Capital | ||||
| Return on Equity | 34.76% | 30.52% | 25% | |
| Return on Assets | — | 18.72% | — | 50% |
| Return on Capital Employed | — | 32.78% | — | 50% |
| ▸DuPont factors (ROE drivers) · 3 ratios | ||||
| ▸Earnings quality · 6 ratios | ||||
| ▸Liquidity & coverage · 6 ratios | ||||
| ▸Capital allocation · 3 ratios | ||||
| ▸Other · 1 ratios | ||||
| Line | 2023 | 2024 |
|---|---|---|
| Operating Income | €73.0M | €73.2M |
| YoY % | +0.3% | |
| Interest Expense | €2.3M | €1.7M |
| YoY % | -28.4% | |
| Interest & Investment Income | €1.2M | €1.7M |
| YoY % | +35.1% | |
| Equity Method Income | €951,000 | €834,000 |
| YoY % | -12.3% | |
| Pretax Income | €72.1M | €72.8M |
| YoY % | +1.0% | |
| Income Tax | €15.2M | €15.5M |
| YoY % | +2.3% | |
| Net Income (incl. NCI) | €56.9M | €57.3M |
| YoY % | +0.7% | |
| Minority Interest (P&L) | €4.0M | €1.8M |
| YoY % | -54.3% | |
| Net Income | €52.9M | €55.5M |
| YoY % | +4.9% |
Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
